References
- Lippi G, Blanckaert N, Bonini P, Green S, Kitchen S, Palicka V, et al. Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories. Clin Chem Lab Med. 2008;46: 764-772. https://doi.org/10.1515/CCLM.2008.170
- Marques-Garcia F, Jung DHH, Perez SE. Impact of individualized hemolysis management based on biological variation cut-offs in a clinical laboratory. Ann Lab Med. 2022;42:169-177. https://doi.org/10.3343/alm.2022.42.2.169
- Plebani M, Sciacovelli L, Aita A, Pelloso M, Chiozza ML. Performance criteria and quality indicators for the pre-analytical phase. Clin Chem Lab Med. 2015;53:943-948. https://doi.org/10.1515/cclm-2014-1124
- Simundic AM, Nikolac N, Ivankovic V, Ferenec-Ruzic D, Magdic B, Kvaternik M, et al. Comparison of visual vs. automated detection of lipemic, icteric and hemolyzed specimens: can we rely on a human eye? Clin Chem Lab Med. 2009;47:1361-1365. https://doi.org/10.1515/CCLM.2009.306
- Wan Azman WN, Omar J, Koon TS, Tuan Ismail TS. Hemolyzed specimens: major challenge for identifying and rejecting specimens in clinical laboratories. Oman Med J. 2019;34:94-98. https://doi.org/10.5001/omj.2019.19
- Marques-Garcia F. Methods for hemolysis interference study in laboratory medicine - a critical review. EJIFCC. 2020;31:85-97.
- Simundic AM, Baird G, Cadamuro J, Costelloe SJ, Lippi G. Managing hemolyzed samples in clinical laboratories. Crit Rev Clin Lab Sci. 2020;57:1-21. https://doi.org/10.1080/10408363.2019.1664391
- Jacobsz LA, Zemlin AE, Roos MJ, Erasmus RT. Chemistry and haematology sample rejection and clinical impact in a tertiary laboratory in Cape Town. Clin Chem Lab Med. 2011;49:2047-2050. https://doi.org/10.1515/CCLM.2011.743
- Sung YH, Hwang MS, Lee JH, Park HD, Ryu KH, Cho MS, et al. [A comparison of the rates of hemolysis and repeated blood sampling using syringe needles versus vacuum tube needles in the emergency department]. J Korean Acad Nurs. 2012;42:443-451. Korean. https://doi.org/10.4040/jkan.2012.42.3.443
- Lippi G, von Meyer A, Cadamuro J, Simundic AM. Blood sample quality. Diagnosis. 2019;6:25-31. https://doi.org/10.1515/dx2018-0018
- Koseoglu M, Hur A, Atay A, Cuhadar S. Effects of hemolysis interferences on routine biochemistry parameters. Biochem Med. 2011;21:79-85. https://doi.org/10.11613/bm.2011.015
- Frank JJ, Bermes EW, Bickel MJ, Watkins BF. Effect of in vitro hemolysis on chemical values for serum. Clin Chem. 1978;24:1966-1970. https://doi.org/10.1093/clinchem/24.11.1966
- Lippi G, Musa R, Avanzini P, Aloe R, Pipitone S, Sandei F. Influence of in vitro hemolysis on hematological testing on Advia 2120. Int J Lab Hematol. 2012;34:179-184. https://doi.org/10.1111/j.1751-553X.2011.01378.x
- Delgado JA, Morell-Garcia D, Bauca JM. Hemolysis interference studies: the particular case of sodium ion. EJIFCC. 2019;30:25-34.
- Lippi G, Cadamuro J, von Meyer A, Simundic AM; European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for Preanalytical Phase (WG-PRE). Practical recommendations for managing hemolyzed samples in clinical chemistry testing. Clin Chem Lab Med. 2018;56:718-727. https://doi.org/10.1515/cclm-2017-1104
- Sonntag O. Haemolysis as an interference factor in clinical chemistry. J Clin Chem Clin Biochem. 1986;24:127-139. https://doi.org/10.1515/cclm.1986.24.2.127
- Greene DN, Holmes DT, Lin MJ, Liang JY, Lorey TS, Schmidt RL. Development of an equation to correct for hemolysis in direct bilirubin measurements. Clin Chim Acta. 2014;429:194-197. https://doi.org/10.1016/j.cca.2013.12.023
- Farrell CJ, Carter AC. Serum indices: managing assay interference. Ann Clin Biochem. 2016;53:527-538. https://doi.org/10.1177/0004563216643557
- Meites S. Letter: reproducibly simulating hemolysis, for evaluating its interference with chemical methods. Clin Chem. 1973;19:1319.
- Glick MR, Ryder KW, Jackson SA. Graphical comparisons of interferences in clinical chemistry instrumentation. Clin Chem. 1986;32:470-475. https://doi.org/10.1093/clinchem/32.3.470
- McEnroe RJ. Interference testing in clinical chemistry: approved guideline. 3rd ed. Clinical and Laboratory Standards Institute: 2018. p7-57.
- Smith MB. Clinical and Laboratory Standards Institute. Vol. 32, Hemolysis, icterus, and lipemia/turbidity indices as indicators of interference in clinical laboratory analysis; approved guideline. CLSI: 2012. p8-37.
- Pyo SS, Nam HS, Cha YJ, Lee S, Lee HK. Harmonization of hemolysis index in clinical chemistry laboratory and its application as a result verification tool. Korean J Clin Lab Sci. 2017;49:350-358. https://doi.org/10.15324/kjcls.2017.49.4.350
- Won DI, Jin HK, Yoon KJ. Mathematical correction of hemolysis interference with hemolysis index. J Clin Pathol Qual Control. 2000;22:175-180.
- Lippi G, Avanzini P, Pavesi F, Bardi M, Ippolito L, Aloe R, et al. Studies on in vitro hemolysis and utility of corrective formulas for reporting results on hemolyzed specimens. Biochem Med. 2011;21:297-305. https://doi.org/10.11613/bm.2011.040
- Bonini P, Plebani M, Ceriotti F, Rubboli F. Errors in laboratory medicine. Clin Chem. 2002;48:691-698. https://doi.org/10.1093/clinchem/48.5.691
- Lippi G, Blanckaert N, Bonini P, Green S, Kitchen S, Palicka V, et al. Causes, consequences, detection, and prevention of identification errors in laboratory diagnostics. Clin Chem Lab Med. 2009;47:143-153. https://doi.org/10.1515/CCLM.2009.045